781 related articles for article (PubMed ID: 8666909)
21. 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium.
Takata S; Papayianni A; Matsubara M; Jimenez W; Pronovost PH; Brady HR
Am J Pathol; 1994 Sep; 145(3):541-9. PubMed ID: 8080039
[TBL] [Abstract][Full Text] [Related]
22. Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.
O'Flaherty JT; Jacobson DP; Redman JF
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):241-8. PubMed ID: 1332696
[TBL] [Abstract][Full Text] [Related]
23. Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism.
Damtew B; Spagnuolo PJ
Inflammation; 1992 Oct; 16(5):425-36. PubMed ID: 1330924
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
26. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein.
Silva AR; de Assis EF; Caiado LF; Marathe GK; Bozza MT; McIntyre TM; Zimmerman GA; Prescott SM; Bozza PT; Castro-Faria-Neto HC
J Immunol; 2002 Apr; 168(8):4112-20. PubMed ID: 11937571
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
Grimminger F; Sibelius U; Aktories K; Suttorp N; Seeger W
Mol Pharmacol; 1991 Oct; 40(4):563-71. PubMed ID: 1656192
[TBL] [Abstract][Full Text] [Related]
28. Enhancement by GM-CSF of agonist-induced 5-lipoxygenase activation in human neutrophils involves protein synthesis and gene transcription.
McDonald PP; Pouliot M; Borgeat P
J Lipid Mediat; 1993; 6(1-3):59-67. PubMed ID: 8358016
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
McIntyre TM; Reinhold SL; Prescott SM; Zimmerman GA
J Biol Chem; 1987 Nov; 262(32):15370-6. PubMed ID: 2824456
[TBL] [Abstract][Full Text] [Related]
30. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
31. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils.
McDonald PP; Pouliot M; Borgeat P; McColl SR
J Immunol; 1993 Dec; 151(11):6399-409. PubMed ID: 8245474
[TBL] [Abstract][Full Text] [Related]
32. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
Dubois C; Bissonnette E; Rola-Pleszczynski M
J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of calcimycin-induced stimulation of cytosolic calcium in human PMN by a LTB4 receptor antagonist.
Heckenberger R; Schrör K
Eicosanoids; 1992; 5 Suppl():S23-5. PubMed ID: 1333252
[TBL] [Abstract][Full Text] [Related]
34. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
Thurston AW; Rhee SG; Shukla SD
J Pharmacol Exp Ther; 1993 Aug; 266(2):1106-12. PubMed ID: 7689100
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
36. Effects of acrolein on leukotriene biosynthesis in human neutrophils.
Berry KA; Henson PM; Murphy RC
Chem Res Toxicol; 2008 Dec; 21(12):2424-32. PubMed ID: 19548361
[TBL] [Abstract][Full Text] [Related]
37. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
[TBL] [Abstract][Full Text] [Related]
38. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.
McDonald PP; McColl SR; Naccache PH; Borgeat P
Br J Pharmacol; 1992 Sep; 107(1):226-32. PubMed ID: 1330161
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.
Shindo K; Koide K; Fukumura M
Thorax; 1997 Dec; 52(12):1024-9. PubMed ID: 9516893
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
